<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Stealth BioTherapeutics Corp.

    Stealth BioTherapeutics Corp.

    We are an innovative biopharmaceutical company developing therapies to treat the m...

    We are an innovative biopharmaceutical company ...

    Filing Type:    PU
    ImmuCell Corporation

    ImmuCell Corporation

    ImmuCell Corporation’s (Nasdaq: ICCC) purpose is to create scientifically-proven...

    ImmuCell Corporation’s (Nasdaq: ICCC) purpose...

    Filing Type:    PU
    Nemucore Medical Innovations, Inc.

    Nemucore Medical Innovations, Inc.

    Nemucore Medical Innovations is here to bring you the future of cancer care. Theyâ...

    Nemucore Medical Innovations is here to bring y...

    Amount Raised:    $92,318.00
    Fundraising Status:    EC
    Filing Type:    CF
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    Tricida, Inc.

    Tricida, Inc.

    Tricida, Inc. , Tricida, Inc. , is a pharmaceutical company focused on the develop...

    Tricida, Inc. , Tricida, Inc. , is a pharmaceut...

    Filing Type:    PU
    Karuna Therapeutics, Inc.

    Karuna Therapeutics, Inc.

    We are an innovative clinical-stage biopharmaceutical company primarily focused on...

    We are an innovative clinical-stage biopharmace...

    Filing Type:    PU
    Advaxis, Inc.

    Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of ca...

    Advaxis was founded on the vision that no one s...

    Filing Type:    PU
    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc.

    SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focused...

    SELLAS Life Sciences Group, Inc. is a late-stag...

    Filing Type:    PU
    Innovation Pharmaceuticals Inc.

    Innovation Pharmaceuticals Inc.

    Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pha...

    Established in 2007, and headquartered in Wakef...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.